Action 2192 MEDLIVE TECHNOLOGY CO., LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Medlive Technology Co., Ltd.

Actions

2192

KYG5961B1041

Marché Fermé - Hong Kong S.E.
Autres places de cotation
 10:09:09 25/04/2024 		Varia. 5j. Varia. 1 janv.
8,27 HKD +0,73 % Graphique intraday de Medlive Technology Co., Ltd. +10,12 % -2,48 %
25/03 Medlive Technology Co. annonce ses résultats pour l'exercice clos le 31 décembre 2023 CI
28/02 Medlive Technology va doubler ses bénéfices en 2023 MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Medlive Technology Co., Ltd. Proposes Final Dividend for the Year Ended December 31, 2023, Payable on June 24, 2024
Medlive Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Medlive Technology to Double Profit in 2023
Medlive Technology Co., Ltd. Provides Earnings Guidance for the Year Ended 31 December 2023
Medlive to Buy 60% of Chinese Pharma Consulting Firm for Some 34 Million Yuan
Medlive Technology’s Profit Soars 266% in H1
Medlive Technology Co., Ltd. Announces Interim Dividend for the Six Months Ended 30 June 2023, Payable on 04 December 2023
Medlive Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Medlive Technology to More than Triple H1 Profit
Medlive Technology Co., Ltd. Provides Earnings Guidance for the Six Months Ended 30 June 2023
Medlive Technology Unit to Buy 50% Stake in Beijing SCMedcon
Medlive Technology Co., Ltd. Announces Executive Changes
Medlive Technology Co., Ltd. Announces Director Changes
Medlive Technology Co., Ltd. Proposes Final Cash Dividend for the Year Ended December 31, 2022, Payable on July 10, 2023
Medlive Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Medlive Technology's Profit to Rise in 2022
Medlive Technology Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ended 31 December 2022
M3's Fiscal Nine-month Attributable Profit Drops 30% on Increased Operating Costs
Medlive Technology Sees No Explanation For Unusual Share Price Movement
M3's Fiscal H1 Attributable Profit Plunges 41% on High-base Effect
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 2192
  4. Actualités Medlive Technology Co., Ltd.
  5. Autres langues